<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">gastro-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал гастроэнтерологии, гепатологии, колопроктологии</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Gastroenterology, Hepatology, Coloproctology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1382-4376</issn><issn pub-type="epub">2658-6673</issn><publisher><publisher-name>«Gastro» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">gastro-j-1139</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ГЕПАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>HEPATOLOGY</subject></subj-group></article-categories><title-group><article-title>Медиаторы межклеточных взаимодействий и гистологические проявления хронической вирусной патологии печени</article-title><trans-title-group xml:lang="en"><trans-title>Mediators of intercellular interactions and histological signs of chronic viral liver disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корой</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Koroy</surname><given-names>P. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Корой Павел Владимирович – доктор медицинских наук, профессор кафедры госпитальной терапии</p><p>355017, г. Ставрополь, ул. Мира, 310</p></bio><bio xml:lang="en"><p>Koroy Pavel V — MD, PhD, professor, chair of hospital course of internal diseases</p><p>Stavropol, Mira street, 310</p></bio><email xlink:type="simple">paule75@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ягода</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yagoda</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ягода Александр Валентинович – доктор медицинских наук, профессор, заведующий кафедрой госпитальной терапии</p><p>355017, г. Ставрополь, ул. Мира, 310</p></bio><bio xml:lang="en"><p>Yagoda Alexander V — MD, PhD, professor, head of the chair of hospital course of internal diseases</p><p>355017, Stavropol, Mira street, 310</p></bio><email xlink:type="simple">alexander.yagoda@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гилязова</surname><given-names>Г. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Gilyazova</surname><given-names>G. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мухорамова</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Mukhoramova</surname><given-names>I. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ГБОУ ВПО «Ставропольский государственный медицинский университет» Минздрава России<country>Россия</country></aff><aff xml:lang="en">State educational government-financed institution of higher professional education «Stavropol state medical university» Ministry of Healthcare of Russian Federation<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>22</day><month>04</month><year>2024</year></pub-date><volume>24</volume><issue>5</issue><fpage>22</fpage><lpage>28</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Корой П.В., Ягода А.В., Гилязова Г.И., Мухорамова И.С., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Корой П.В., Ягода А.В., Гилязова Г.И., Мухорамова И.С.</copyright-holder><copyright-holder xml:lang="en">Koroy P.V., Yagoda A.V., Gilyazova G.I., Mukhoramova I.S.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gastro-j.ru/jour/article/view/1139">https://www.gastro-j.ru/jour/article/view/1139</self-uri><abstract><p>Цель исследования. Установление взаимосвязи медиаторов межклеточных взаимодействий с гистологическими изменениями при хронической вирусной патологии печени.Материал и методы. У 101 больного хроническими вирусными заболеваниями печени изучено содержание в крови молекул суперсемейства иммуноглобулинов и селектинов. Показатели ICAM-1, VCAM-1, Е-селектина, L-селектина и Р-селектина, определяемые методом иммуноферментного анализа, сопоставлялись со значениями индексов гистологической активности по Knodell и фиброза по Desmet, а также с величинами стеатоза печени, оцениваемого по E. M. Brunt.Результаты. При хроническом вирусном гепатите отмечалось увеличение в крови содержания ICAM-1 и селектинов, тогда как у пациентов с циррозом печени регистрировалось повышение значений всех адгезинов. Концентрация ICAM-1, VCAM-1, Е-, Lи Р-селектина при хронических вирусных заболеваниях печени увеличивалась с ростом выраженности воспаления и тяжести печеночного фиброза и имела позитивную корреляцию с индексами гистологической активности (ИГА) и фиброза печени. Установлена прямая связь ICAM-1, VCAM-1 и Е-селектина со степенью печеночного стеатоза. Определены значения молекул суперсемейства иммуноглобулинов и селектинов, которые характеризовались достаточной точностью в обнаружении ИГА более 8 баллов и выявлении умеренного/тяжелого фиброза.Выводы. Ассоциация морфологических проявлений с медиаторами межклеточных взаимодействий свидетельствует о их важной роли в формировании и прогрессировании хронической вирусной патологии печени.</p></abstract><trans-abstract xml:lang="en"><sec><title>Aim of investigation</title><p>Aim of investigation. To establish interrelation of intercellular interaction mediators with histological changes at chronic viral liver disease.</p></sec><sec><title>Material and methods</title><p>Material and methods. Blood contents of immunoglobulins superfamily and selectin molecules was investigated in 101 patients with chronic viral liver diseases. Scores of ICAM-1, VCAM-1, Е-selectin, L-selectin and the Р-selectin were determined by enzyme-linked immunoassay method and were compared to values of Knodell histological activity index and Desmet fibrosis score as well as to E.M. Brunt hepatic steatosis levels.</p></sec><sec><title>Results</title><p>Results. At chronic viral hepatitis ICAM-1 and selectins blood contents increase whereas in patients with liver cirrhosis elevation of all adhesin levels was marked. Concentration of ICAM-1, VCAM-1, Е-, L-and Р-selectin at chronic viral liver diseases was increased along with increase of severity of inflammation and severity of hepatic fibrosis and had positive correlation with histological activity indexes (HAI) and liver fibrosis. Positive correlation of ICAM-1, VCAM-1 and Е-selectin with degree of liver steatosis was found. Level of immunoglobulin superfamily and selectin molecules were characterized by sufficient accuracy in detection of HAI over 8 points and detection of moderate/severe degree of fibrosis.</p></sec><sec><title>Conclusions</title><p>Conclusions. Association of morphological signs with mediators of intercellular interactions indicates their important role in development and progression of chronic viral liver disease.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хронический вирусный гепатит</kwd><kwd>цирроз печени</kwd><kwd>гистологическая активность</kwd><kwd>фиброз</kwd><kwd>молекулы суперсемейства иммуноглобулинов</kwd><kwd>селектины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic viral hepatitis</kwd><kwd>liver cirrhosis</kwd><kwd>histological activity</kwd><kwd>fibrosis</kwd><kwd>molecules of immunoglobulin superfamily</kwd><kwd>selectins</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ягода А.В., Корой П.В. Функциональная активность тромбоцитов и печеночный фиброз при хронической вирусной патологии печени. Возможности неинвазивной диагностики. Экспер клин гастроэнтерол 2006; 5:73-6.</mixed-citation><mixed-citation xml:lang="en">Ягода А.В., Корой П.В. Функциональная активность тромбоцитов и печеночный фиброз при хронической вирусной патологии печени. Возможности неинвазивной диагностики. Экспер клин гастроэнтерол 2006; 5:73-6.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Abdallah N., Morsi M., Hamed N., Abdel Aziz H. Evaluation of prognostic value of cell adhesion molecules in chronic hepatitis C therapy. J Venom Anim Toxins Incl Trop Dis 2010; 16(3):442-8.</mixed-citation><mixed-citation xml:lang="en">Abdallah N., Morsi M., Hamed N., Abdel Aziz H. Evaluation of prognostic value of cell adhesion molecules in chronic hepatitis C therapy. J Venom Anim Toxins Incl Trop Dis 2010; 16(3):442-8.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Abou-Saleh H., Theoret J.F., Yacoub D., Merhi Y. Neutrophil P-selectin-glycoprotein-ligand-1 binding to platelet P-selectin enhances metalloproteinase 2 secretion and platelet-neutrophil aggregation. Thromb Haemost 2005; 94:1230-5.</mixed-citation><mixed-citation xml:lang="en">Abou-Saleh H., Theoret J.F., Yacoub D., Merhi Y. Neutrophil P-selectin-glycoprotein-ligand-1 binding to platelet P-selectin enhances metalloproteinase 2 secretion and platelet-neutrophil aggregation. Thromb Haemost 2005; 94:1230-5.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bruno C.M., Sciacca C., Cilio D., et al. Circulating adhesion molecules in patients with virus-related chronic diseases of the liver. World J Gastroenterol 2005; 11(29):4566-9.</mixed-citation><mixed-citation xml:lang="en">Bruno C.M., Sciacca C., Cilio D., et al. Circulating adhesion molecules in patients with virus-related chronic diseases of the liver. World J Gastroenterol 2005; 11(29):4566-9.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">De Castro I.F., Micheloud D., Berenguer J., et al. Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients. AIDS 2010; 24(13):2059-67.</mixed-citation><mixed-citation xml:lang="en">De Castro I.F., Micheloud D., Berenguer J., et al. Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients. AIDS 2010; 24(13):2059-67.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">El-Shazly M., Yehia Aly N., El-Shimi I., et al. Soluble intercellular adhesion molecule-1 in sera of patients with chronic hepatitis C. Bull Alexandria Faculty Med 2007; 43(4):25-31.</mixed-citation><mixed-citation xml:lang="en">El-Shazly M., Yehia Aly N., El-Shimi I., et al. Soluble intercellular adhesion molecule-1 in sera of patients with chronic hepatitis C. Bull Alexandria Faculty Med 2007; 43(4):25-31.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007; 117:539-48.</mixed-citation><mixed-citation xml:lang="en">Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007; 117:539-48.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kawasuji A., Hasegawa M., Horikawa M., et al. L-selectin and intercellular adhesion molecule-1 regulate the development of Concanavalin A-induced liver injury. J Leukoc Biol 2006; 79(4):696-705.</mixed-citation><mixed-citation xml:lang="en">Kawasuji A., Hasegawa M., Horikawa M., et al. L-selectin and intercellular adhesion molecule-1 regulate the development of Concanavalin A-induced liver injury. J Leukoc Biol 2006; 79(4):696-705.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kukla M., Zwirska-Korczala K., Gabriel A., et al. Soluble platelet-endothelial cell adhesion molecule-1 and soluble vascular cell adhesion molecule-1: role in pathogenesis and diagnosis of chronic hepatitis C and association with response to antiviral therapy. Therap Adv Gastroenterol 2009; 2(2):79-90.</mixed-citation><mixed-citation xml:lang="en">Kukla M., Zwirska-Korczala K., Gabriel A., et al. Soluble platelet-endothelial cell adhesion molecule-1 and soluble vascular cell adhesion molecule-1: role in pathogenesis and diagnosis of chronic hepatitis C and association with response to antiviral therapy. Therap Adv Gastroenterol 2009; 2(2):79-90.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Laschke M.W., Dold S., Menger M.D., et al. Plateletdependent accumulation of leukocytes in sinusoids mediates hepatocellular damage in bile duct ligation-induced cholestasis. Br J Pharmacol 2008; 153:148-56.</mixed-citation><mixed-citation xml:lang="en">Laschke M.W., Dold S., Menger M.D., et al. Plateletdependent accumulation of leukocytes in sinusoids mediates hepatocellular damage in bile duct ligation-induced cholestasis. Br J Pharmacol 2008; 153:148-56.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Laschke M., Menger M.D., Wang Y., et al. Sepsisassociated cholestasis is critically dependent on P-selectindependent leukocyte recruitment in mice. Am J Physiol Gastroenterol Hepatol Physiol 2007; 292:1396-402.</mixed-citation><mixed-citation xml:lang="en">Laschke M., Menger M.D., Wang Y., et al. Sepsisassociated cholestasis is critically dependent on P-selectindependent leukocyte recruitment in mice. Am J Physiol Gastroenterol Hepatol Physiol 2007; 292:1396-402.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li X., Klintman D., Weitz-Schmidt G., et al. Lymphocyte function antigen-1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic mice. Br J Pharmacol 2004; 141(4):709-16.</mixed-citation><mixed-citation xml:lang="en">Li X., Klintman D., Weitz-Schmidt G., et al. Lymphocyte function antigen-1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic mice. Br J Pharmacol 2004; 141(4):709-16.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lv P., Luo H.S., Zhou X.P., et al. Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear factor-kappaB/inhibitor of nuclear factor-kappaB pathway. Arch Med Res 2007; 38(1):1527.</mixed-citation><mixed-citation xml:lang="en">Lv P., Luo H.S., Zhou X.P., et al. Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear factor-kappaB/inhibitor of nuclear factor-kappaB pathway. Arch Med Res 2007; 38(1):1527.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lv P., Luo H.S., Zhou X.P., et al. Thalidomide prevents rat liver cirrhosis via inhibition of oxidative stress. Pathol Res Pract 2006; 202(11):777-88.</mixed-citation><mixed-citation xml:lang="en">Lv P., Luo H.S., Zhou X.P., et al. Thalidomide prevents rat liver cirrhosis via inhibition of oxidative stress. Pathol Res Pract 2006; 202(11):777-88.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">March S., Garsia-Pagan J.C., Massaguer A., et al. P-selectin mediates leukocyte rolling in concanavalin-Ainduced hepatitis. Liver Int 2005; 25(5):1053-60.</mixed-citation><mixed-citation xml:lang="en">March S., Garsia-Pagan J.C., Massaguer A., et al. P-selectin mediates leukocyte rolling in concanavalin-Ainduced hepatitis. Liver Int 2005; 25(5):1053-60.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Massaguer A., Perez-Del-Pulgar S., Engel P., et al. Concanavalin-A-induced liver injury is severy impaired in mice deficient in P-selectin. J Leukoc Biol 2002; 72(2):262-70.</mixed-citation><mixed-citation xml:lang="en">Massaguer A., Perez-Del-Pulgar S., Engel P., et al. Concanavalin-A-induced liver injury is severy impaired in mice deficient in P-selectin. J Leukoc Biol 2002; 72(2):262-70.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Panasiuk A., Prokopowicz D., Panasiuk B. Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C. World J Gastroenterol 2004; 10(24):3639-42.</mixed-citation><mixed-citation xml:lang="en">Panasiuk A., Prokopowicz D., Panasiuk B. Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C. World J Gastroenterol 2004; 10(24):3639-42.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Panasiuk A., Zak J., Kasprzycka E., et al. Blood platelet and monocyte activations and relation to stages of liver cirrhosis. World J Gastroenterol 2005; 11(18):2754-8.</mixed-citation><mixed-citation xml:lang="en">Panasiuk A., Zak J., Kasprzycka E., et al. Blood platelet and monocyte activations and relation to stages of liver cirrhosis. World J Gastroenterol 2005; 11(18):2754-8.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Paul S.C., Lv P., Xiao Y., et al. Thalidomide in rat liver cirrhosis: blockade of tumor necrosis factor-alpha via inhibition of degradation of an inhibitor of nuclear factorkappaB. Pathobiology 2006; 73(2):82-92.</mixed-citation><mixed-citation xml:lang="en">Paul S.C., Lv P., Xiao Y., et al. Thalidomide in rat liver cirrhosis: blockade of tumor necrosis factor-alpha via inhibition of degradation of an inhibitor of nuclear factorkappaB. Pathobiology 2006; 73(2):82-92.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Pinzani M., Rombouts K., Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 2005; 42:22-36.</mixed-citation><mixed-citation xml:lang="en">Pinzani M., Rombouts K., Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 2005; 42:22-36.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Pinzani M., Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 2004; 36(4):231-42.</mixed-citation><mixed-citation xml:lang="en">Pinzani M., Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 2004; 36(4):231-42.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pockros P.J. Noninvasive markers of fibrosis in chronic hepatitis patients. J Clin Gastroenterol 2006; 40(6):461-3.</mixed-citation><mixed-citation xml:lang="en">Pockros P.J. Noninvasive markers of fibrosis in chronic hepatitis patients. J Clin Gastroenterol 2006; 40(6):461-3.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rui-dan Z., Ya-yong S., Yan-hui L., et al. Alteration of intercellular adhesion molecule-1 (ICAM-1) expression in the liver and serum level of HBV DNA in chronic hepatitis B patients after interferon treatment. African J Microbiol Res 2011; 5(10):1211-4.</mixed-citation><mixed-citation xml:lang="en">Rui-dan Z., Ya-yong S., Yan-hui L., et al. Alteration of intercellular adhesion molecule-1 (ICAM-1) expression in the liver and serum level of HBV DNA in chronic hepatitis B patients after interferon treatment. African J Microbiol Res 2011; 5(10):1211-4.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Tacke F., Schoffski P., Trautwein C., et al. Plasma P-selectin levels are elevated in patients with chronic liver disease. Blood Coagul Fibrinolysis 2003; 14(4):319-25.</mixed-citation><mixed-citation xml:lang="en">Tacke F., Schoffski P., Trautwein C., et al. Plasma P-selectin levels are elevated in patients with chronic liver disease. Blood Coagul Fibrinolysis 2003; 14(4):319-25.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 2007; 218:178-96.</mixed-citation><mixed-citation xml:lang="en">Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 2007; 218:178-96.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Von Hundelshausen P., Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100:27-40.</mixed-citation><mixed-citation xml:lang="en">Von Hundelshausen P., Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100:27-40.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Yu Z., Otsuka H., Yamaguchi K., et al. Roles of platelets and macrophages in the protective effects of lipopolysaccharide against concanavalin A-induced murine hepatitis. Biochim Biophys Acta 2011; 1812(9):1069-79.</mixed-citation><mixed-citation xml:lang="en">Yu Z., Otsuka H., Yamaguchi K., et al. Roles of platelets and macrophages in the protective effects of lipopolysaccharide against concanavalin A-induced murine hepatitis. Biochim Biophys Acta 2011; 1812(9):1069-79.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
